Paper23344239
Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.
Seth PP and 5 others. Mol Ther Nucleic Acids, 2012. Cited by 32 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals. Papers, record 23344239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23344239
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18710289 | Nucleic acid structural engineering using pyrene-functionalized 2'-amino-alpha-L-LNA monomers and abasic sites. | J Org Chem | 2008 | https://conductscience.org/library/papers/18710289 | PubMed |
| 2 | 21075634 | Replacing the 2'-oxygen with an exocyclic methylene group reverses the stabilization effects of α-L-LNA. | Bioorg Med Chem Lett | 2011 | https://conductscience.org/library/papers/21075634 | PubMed |
| 3 | 15357590 | 3'-C-Branched LNA-type nucleosides locked in an N-type furanose ring conformation: synthesis, incorporation into oligodeoxynucleotides, and hybridization studies. | J Org Chem | 2004 | https://conductscience.org/library/papers/15357590 | PubMed |
| 4 | 15861430 | On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide. | Chembiochem | 2005 | https://conductscience.org/library/papers/15861430 | PubMed |
| 5 | 20227758 | Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial. | Lancet | 2010 | https://conductscience.org/library/papers/20227758 | PubMed |
| 6 | 17551917 | 2'-N-(pyren-1-yl)acetyl-2'-amino-alpha-L-LNA: synthesis and detection of single nucleotide mismatches in DNA and RNA targets. | Chembiochem | 2007 | https://conductscience.org/library/papers/17551917 | PubMed |
| 7 | 10985717 | Structural studies of LNA:RNA duplexes by NMR: conformations and implications for RNase H activity. | Chemistry | 2000 | https://conductscience.org/library/papers/10985717 | PubMed |
| 8 | 20055705 | RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. | Annu Rev Pharmacol Toxicol | 2010 | https://conductscience.org/library/papers/20055705 | PubMed |
| 9 | 22530946 | Intramolecular free-radical cyclization reactions on pentose sugars for the synthesis of carba-LNA and carba-ENA and the application of their modified oligonucleotides as potential RNA targeted therapeutics. | Chem Rev | 2012 | https://conductscience.org/library/papers/22530946 | PubMed |
| 10 | 22467214 | TricycloDNA-modified oligo-2'-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues--a comparative study of oligonucleotide length, design and chemistry. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22467214 | PubMed |
| 11 | 18368051 | LNA-mediated microRNA silencing in non-human primates. | Nature | 2008 | https://conductscience.org/library/papers/18368051 | PubMed |
| 12 | 20886816 | An exocyclic methylene group acts as a bioisostere of the 2'-oxygen atom in LNA. | J Am Chem Soc | 2010 | https://conductscience.org/library/papers/20886816 | PubMed |
| 13 | 21709231 | Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs). | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21709231 | PubMed |
| 14 | 20108935 | Antisense oligonucleotides containing conformationally constrained 2',4'-(N-methoxy)aminomethylene and 2',4'-aminooxymethylene and 2'-O,4'-C-aminomethylene bridged nucleoside analogues show improved potency in animal models. | J Med Chem | 2010 | https://conductscience.org/library/papers/20108935 | PubMed |
| 15 | 20615897 | Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20615897 | PubMed |
| 16 | 21058707 | Configuration of the 5'-methyl group modulates the biophysical and biological properties of locked nucleic acid (LNA) oligonucleotides. | J Med Chem | 2010 | https://conductscience.org/library/papers/21058707 | PubMed |
| 17 | 21778053 | Synthesis and biophysical evaluation of 3'-Me-α-L-LNA - Substitution in the minor groove of α-L-LNA duplexes. | Bioorg Med Chem Lett | 2011 | https://conductscience.org/library/papers/21778053 | PubMed |
| 18 | 22614180 | Structure and nuclease resistance of 2',4'-constrained 2'-O-methoxyethyl (cMOE) and 2'-O-ethyl (cEt) modified DNAs. | Chem Commun (Camb) | 2012 | https://conductscience.org/library/papers/22614180 | PubMed |
| 19 | 11878970 | alpha-L-ribo-configured locked nucleic acid (alpha-L-LNA): synthesis and properties. | J Am Chem Soc | 2002 | https://conductscience.org/library/papers/11878970 | PubMed |
| 20 | 10640282 | Chemically modified oligonucleotides exhibit decreased immune stimulation in mice. | J Pharmacol Exp Ther | 2000 | https://conductscience.org/library/papers/10640282 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42814296 | Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42814296 | PubMed |
| 38654375 | Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer's disease. | Mol Neurodegener | 2024 | https://conductscience.org/library/papers/38654375 | PubMed |
| 38042877 | Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry. | Nat Commun | 2023 | https://conductscience.org/library/papers/38042877 | PubMed |
| 33876937 | Nuclease Hydrolysis Does Not Drive the Rapid Signaling Decay of DNA Aptamer-Based Electrochemical Sensors in Biological Fluids. | Langmuir | 2021 | https://conductscience.org/library/papers/33876937 | PubMed |
| 33544849 | Site-specific incorporation of 5'-methyl DNA enhances the therapeutic profile of gapmer ASOs. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33544849 | PubMed |
| 30913332 | Mirror-Image Oligonucleotides: History and Emerging Applications. | Chemistry | 2019 | https://conductscience.org/library/papers/30913332 | PubMed |
| 29499955 | A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides. | Mol Ther Nucleic Acids | 2018 | https://conductscience.org/library/papers/29499955 | PubMed |
| 29246296 | Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/29246296 | PubMed |
| 29107969 | Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia. | PLoS One | 2017 | https://conductscience.org/library/papers/29107969 | PubMed |
| 29062429 | Enzymatic separation of epimeric 4-C-hydroxymethylated furanosugars: Synthesis of bicyclic nucleosides. | Beilstein J Org Chem | 2017 | https://conductscience.org/library/papers/29062429 | PubMed |
| 29052679 | Oligonucleotide modifications enhance probe stability for single cell transcriptome in vivo analysis (TIVA). | Org Biomol Chem | 2017 | https://conductscience.org/library/papers/29052679 | PubMed |
| 27466159 | Development of Antisense Drugs for Dyslipidemia. | J Atheroscler Thromb | 2016 | https://conductscience.org/library/papers/27466159 | PubMed |
| 27461380 | Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides. | Sci Rep | 2016 | https://conductscience.org/library/papers/27461380 | PubMed |
| 27061947 | Injection site reactions after subcutaneous oligonucleotide therapy. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/27061947 | PubMed |
| 26890856 | A novel dual lock method for down-regulation of genes, in which a target mRNA is captured at 2 independent positions by linked locked nucleic acid antisense oligonucleotides. | RNA Biol | 2016 | https://conductscience.org/library/papers/26890856 | PubMed |
| 26553810 | Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26553810 | PubMed |
| 26258894 | DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing. | Nat Commun | 2015 | https://conductscience.org/library/papers/26258894 | PubMed |
| 25334092 | Targeting of repeated sequences unique to a gene results in significant increases in antisense oligonucleotide potency. | PLoS One | 2014 | https://conductscience.org/library/papers/25334092 | PubMed |
| 25072142 | Defining the factors that contribute to on-target specificity of antisense oligonucleotides. | PLoS One | 2014 | https://conductscience.org/library/papers/25072142 | PubMed |
| 24797769 | C5-alkynyl-functionalized α-L-LNA: synthesis, thermal denaturation experiments and enzymatic stability. | J Org Chem | 2014 | https://conductscience.org/library/papers/24797769 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23344239
GET https://conductscience.org/api/papers/v1/23344239/references?page=2